{
  "issues": [
    "Agent 2 recommends CT_TRAUMA_CHEST_ABD_PELVIS but notes that a dedicated thoracic aorta CTA sequence and a pulmonary arterial phase are needed; the listed protocol description only mentions a portal venous phase and does not guarantee inclusion of an arterial aortic phase, which is essential for evaluating a thoracic aortic injury.",
    "Pre‑contrast hydration of 1 L normal saline may be excessive in a patient with severe hypotension and possible ongoing hemorrhage; fluid administration should be individualized and balanced against the risk of volume overload.",
    "The recommendation does not explicitly address contrast dose reduction or use of low‑osmolar contrast agents, which are recommended when the patient is hemodynamically unstable despite a high eGFR.",
    "No explicit plan for vasopressor support or for confirming hemodynamic stability before administering contrast, despite a MAP of 49.3 mmHg (below the typical 60 mmHg threshold for safe contrast administration).",
    "Renal tool summary includes a contradictory reason: \"Missing BMI or creatinine\" despite creatinine being present; this inconsistency should be flagged for the tool’s developers."
  ],
  "recommendations": [
    "Select a trauma CT protocol that explicitly includes an arterial phase for thoracic aortic evaluation (e.g., CT Aortic Angiography) and a pulmonary arterial phase; modify the CT_TRAUMA_CHEST_ABD_PELVIS protocol to add a dedicated aortic arterial phase (e.g., 20–30 s post‑contrast).",
    "Administer a controlled, modest fluid bolus (e.g., 250–500 mL normal saline over 15–30 min) after assessing volume status, and coordinate with the ICU team to titrate fluids or vasopressors to achieve a MAP ≥ 60 mmHg before contrast administration.",
    "Use low‑osmolar or iso‑osmolar iodinated contrast at the minimal effective volume (e.g., weight‑based 1.5 mL/kg, split‑bolus technique) to reduce total iodine load, especially given the patient’s hemodynamic instability.",
    "Implement real‑time hemodynamic monitoring during contrast injection, with immediate availability of vasopressor agents (e.g., norepinephrine) to support MAP ≥ 60 mmHg throughout the scan.",
    "Obtain baseline renal labs (creatinine, BUN) prior to contrast and repeat at 24 h and 48 h post‑contrast; consider bedside ultrasound or TEE for aortic assessment if the patient cannot be safely stabilized for CT contrast.",
    "Document and resolve the inconsistency in the renal tool’s summary regarding missing BMI/creatinine to improve future decision support."
  ],
  "confidence": 0.87,
  "agent2_confidence": 0.65,
  "timestamp": "2025-08-15T15:33:10.444380Z",
  "tool_outputs": {
    "renal": {
      "tool_id": "renal_tool_v2",
      "checks": [
        {
          "id": "egfr_ckd_epi",
          "units": "ml/min/1.73m2",
          "timestamp": "2025-08-15T15:33:01.638775Z",
          "priority": "critical",
          "value": 135.1,
          "status": "pass",
          "reason": "Low renal risk for contrast."
        },
        {
          "id": "creatinine_mg_dl",
          "units": "mg/dL",
          "timestamp": "2025-08-15T15:33:01.638782Z",
          "priority": "critical",
          "value": 0.5,
          "status": "pass",
          "reason": "Creatinine within normal range."
        },
        {
          "id": "bun_creatinine_ratio",
          "timestamp": "2025-08-15T15:33:01.638785Z",
          "priority": "important",
          "value": 16.0,
          "status": "pass",
          "reason": "BUN/Cr ratio normal."
        },
        {
          "id": "potassium_mmol_l",
          "units": "mEq/L",
          "timestamp": "2025-08-15T15:33:01.638792Z",
          "priority": "important",
          "value": 3.6,
          "status": "pass",
          "reason": "Potassium normal."
        }
      ],
      "summary": {
        "overall": "pass",
        "reasons": [
          "Missing BMI or creatinine.",
          "No lab timestamps provided."
        ],
        "confidence": 0.92
      },
      "metadata": {
        "version": "2.0.0",
        "run_ts": "2025-08-15T15:33:01.638812Z"
      }
    }
  },
  "llm_raw": "{\n  \"issues\": [\n    \"Agent 2 recommends CT_TRAUMA_CHEST_ABD_PELVIS but notes that a dedicated thoracic aorta CTA sequence and a pulmonary arterial phase are needed; the listed protocol description only mentions a portal venous phase and does not guarantee inclusion of an arterial aortic phase, which is essential for evaluating a thoracic aortic injury.\",\n    \"Pre‑contrast hydration of 1 L normal saline may be excessive in a patient with severe hypotension and possible ongoing hemorrhage; fluid administration should be individualized and balanced against the risk of volume overload.\",\n    \"The recommendation does not explicitly address contrast dose reduction or use of low‑osmolar contrast agents, which are recommended when the patient is hemodynamically unstable despite a high eGFR.\",\n    \"No explicit plan for vasopressor support or for confirming hemodynamic stability before administering contrast, despite a MAP of 49.3 mmHg (below the typical 60 mmHg threshold for safe contrast administration).\",\n    \"Renal tool summary includes a contradictory reason: \\\"Missing BMI or creatinine\\\" despite creatinine being present; this inconsistency should be flagged for the tool’s developers.\"\n  ],\n  \"recommendations\": [\n    \"Select a trauma CT protocol that explicitly includes an arterial phase for thoracic aortic evaluation (e.g., CT Aortic Angiography) and a pulmonary arterial phase; modify the CT_TRAUMA_CHEST_ABD_PELVIS protocol to add a dedicated aortic arterial phase (e.g., 20–30 s post‑contrast).\",\n    \"Administer a controlled, modest fluid bolus (e.g., 250–500 mL normal saline over 15–30 min) after assessing volume status, and coordinate with the ICU team to titrate fluids or vasopressors to achieve a MAP ≥ 60 mmHg before contrast administration.\",\n    \"Use low‑osmolar or iso‑osmolar iodinated contrast at the minimal effective volume (e.g., weight‑based 1.5 mL/kg, split‑bolus technique) to reduce total iodine load, especially given the patient’s hemodynamic instability.\",\n    \"Implement real‑time hemodynamic monitoring during contrast injection, with immediate availability of vasopressor agents (e.g., norepinephrine) to support MAP ≥ 60 mmHg throughout the scan.\",\n    \"Obtain baseline renal labs (creatinine, BUN) prior to contrast and repeat at 24 h and 48 h post‑contrast; consider bedside ultrasound or TEE for aortic assessment if the patient cannot be safely stabilized for CT contrast.\",\n    \"Document and resolve the inconsistency in the renal tool’s summary regarding missing BMI/creatinine to improve future decision support.\"\n  ],\n  \"confidence\": 0.87\n}",
  "hallucination_analysis": {
    "statement_assessments": [
      {
        "text": "Agent 2 recommends CT_TRAUMA_CHEST_ABD_PELVIS but notes that a dedicated thoracic aorta CTA sequence and a pulmonary arterial phase are needed; the listed protocol description only mentions a portal venous phase and does not guarantee inclusion of an arterial aortic phase, which is essential for evaluating a thoracic aortic injury.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Pre‑contrast hydration of 1 L normal saline may be excessive in a patient with severe hypotension and possible ongoing hemorrhage; fluid administration should be individualized and balanced against the risk of volume overload.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "The recommendation does not explicitly address contrast dose reduction or use of low‑osmolar contrast agents, which are recommended when the patient is hemodynamically unstable despite a high eGFR.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "No explicit plan for vasopressor support or for confirming hemodynamic stability before administering contrast, despite a MAP of 49.3 mmHg (below the typical 60 mmHg threshold for safe contrast administration).",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "Renal tool summary includes a contradictory reason: \"Missing BMI or creatinine\" despite creatinine being present; this inconsistency should be flagged for the tool’s developers.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Select a trauma CT protocol that explicitly includes an arterial phase for thoracic aortic evaluation (e.g., CT Aortic Angiography) and a pulmonary arterial phase; modify the CT_TRAUMA_CHEST_ABD_PELVIS protocol to add a dedicated aortic arterial phase (e.g., 20–30 s post‑contrast).",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "Administer a controlled, modest fluid bolus (e.g., 250–500 mL normal saline over 15–30 min) after assessing volume status, and coordinate with the ICU team to titrate fluids or vasopressors to achieve a MAP ≥ 60 mmHg before contrast administration.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "Use low‑osmolar or iso‑osmolar iodinated contrast at the minimal effective volume (e.g., weight‑based 1.5 mL/kg, split‑bolus technique) to reduce total iodine load, especially given the patient’s hemodynamic instability.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Implement real‑time hemodynamic monitoring during contrast injection, with immediate availability of vasopressor agents (e.g., norepinephrine) to support MAP ≥ 60 mmHg throughout the scan.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "Obtain baseline renal labs (creatinine, BUN) prior to contrast and repeat at 24 h and 48 h post‑contrast; consider bedside ultrasound or TEE for aortic assessment if the patient cannot be safely stabilized for CT contrast.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Document and resolve the inconsistency in the renal tool’s summary regarding missing BMI/creatinine to improve future decision support.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      }
    ],
    "counts": {
      "supported": 11,
      "inferred": 0,
      "domain_safe": 0,
      "unverified": 0,
      "contradicted": 0
    },
    "hallucination_score": 0.0,
    "recommendation": {
      "force_revision": false,
      "confidence_reduction": 0.0
    },
    "knowledge_base_summary": {
      "numbers": {
        "subject_id": 10014729.0,
        "hadm_id": 28889419.0,
        "stay_id": 33558396.0,
        "age": 21.0,
        "hospital_expire_flag": 0.0,
        "los_hospital_days": 2.47,
        "los_icu_days": 2.47,
        "creatinine_mg_dl": 0.5,
        "bun_mg_dl": 8.0,
        "glucose_mg_dl": 76.0,
        "hemoglobin_g_dl": 10.3,
        "hematocrit_pct": 29.9,
        "platelet_count": 229.0,
        "wbc_count": 6.9,
        "sodium_meq_l": 137.0,
        "potassium_mmol_l": 3.6,
        "chloride_meq_l": 97.0,
        "bicarbonate_meq_l": 25.0,
        "egfr_ckd_epi": 135.1,
        "ckd_stage": 1.0,
        "bun_creatinine_ratio": 16.0,
        "heart_rate_bpm": 107.0,
        "systolic_bp_mmhg": 78.0,
        "diastolic_bp_mmhg": 35.0,
        "map_mmhg": 49.3,
        "pulse_pressure_mmhg": 43.0,
        "temperature_f": 99.1,
        "spo2_pct": 98.0,
        "respiratory_rate": 18.0,
        "data_completeness_pct": 0.95
      },
      "raw_strings_sample": [
        "137.0",
        "creatinine within normal range.",
        "white - other european",
        "43.0",
        "bun_creatinine_ratio",
        "0.95",
        "8.0",
        "low renal risk for contrast.",
        "stage 1 (normal)",
        "0"
      ]
    }
  },
  "feedback": {
    "issues": [
      "Agent 2 recommends CT_TRAUMA_CHEST_ABD_PELVIS but notes that a dedicated thoracic aorta CTA sequence and a pulmonary arterial phase are needed; the listed protocol description only mentions a portal venous phase and does not guarantee inclusion of an arterial aortic phase, which is essential for evaluating a thoracic aortic injury.",
      "Pre‑contrast hydration of 1 L normal saline may be excessive in a patient with severe hypotension and possible ongoing hemorrhage; fluid administration should be individualized and balanced against the risk of volume overload.",
      "The recommendation does not explicitly address contrast dose reduction or use of low‑osmolar contrast agents, which are recommended when the patient is hemodynamically unstable despite a high eGFR.",
      "No explicit plan for vasopressor support or for confirming hemodynamic stability before administering contrast, despite a MAP of 49.3 mmHg (below the typical 60 mmHg threshold for safe contrast administration).",
      "Renal tool summary includes a contradictory reason: \"Missing BMI or creatinine\" despite creatinine being present; this inconsistency should be flagged for the tool’s developers."
    ],
    "recommendations": [
      "Select a trauma CT protocol that explicitly includes an arterial phase for thoracic aortic evaluation (e.g., CT Aortic Angiography) and a pulmonary arterial phase; modify the CT_TRAUMA_CHEST_ABD_PELVIS protocol to add a dedicated aortic arterial phase (e.g., 20–30 s post‑contrast).",
      "Administer a controlled, modest fluid bolus (e.g., 250–500 mL normal saline over 15–30 min) after assessing volume status, and coordinate with the ICU team to titrate fluids or vasopressors to achieve a MAP ≥ 60 mmHg before contrast administration.",
      "Use low‑osmolar or iso‑osmolar iodinated contrast at the minimal effective volume (e.g., weight‑based 1.5 mL/kg, split‑bolus technique) to reduce total iodine load, especially given the patient’s hemodynamic instability.",
      "Implement real‑time hemodynamic monitoring during contrast injection, with immediate availability of vasopressor agents (e.g., norepinephrine) to support MAP ≥ 60 mmHg throughout the scan.",
      "Obtain baseline renal labs (creatinine, BUN) prior to contrast and repeat at 24 h and 48 h post‑contrast; consider bedside ultrasound or TEE for aortic assessment if the patient cannot be safely stabilized for CT contrast.",
      "Document and resolve the inconsistency in the renal tool’s summary regarding missing BMI/creatinine to improve future decision support."
    ],
    "confidence": 0.87
  }
}